Total Funding
68
39
Total FundingSeed raised
Growth Score
-7 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17488
Optic is an AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validation.
- Andrey Doronichev: Founder and CEOPast Role: Mesto, Co-Founder
- Vlad Vinogradov: Co-Founder and CTOPast Role: EORA, Co-Founder and Head of AI
About the Company
Optic, an AI Drug Discovery company, is based in San Francisco. Our proprietary ligand-based and target-driven molecular search engine Bioptic.io identifies compounds by their activity-expressing fingerprints. It offers a novel approach to finding diverse candidate sets. In addition, we now also have an agentic AI platform for scientific and
business due diligence on drug assets. Our pipeline includes multiple pre-clinical stage programs, showcasing our commitment to practical, AI-driven solutions in cancer therapy.
